Evaluation of Temperature Gradient Capillary Electrophoresis for Detection of the Factor V Leiden Mutation

[1]  S. Ogino,et al.  Quantification of PCR bias caused by a single nucleotide polymorphism in SMN gene dosage analysis. , 2002, The Journal of molecular diagnostics : JMD.

[2]  Zhaowei Liu,et al.  Integrated platform for detection of DNA sequence variants using capillary array electrophoresis , 2002, Electrophoresis.

[3]  B. Gold,et al.  Two Rare Confounding Polymorphisms Proximal to the Factor V Leiden Mutation , 2001, Molecular Diagnosis.

[4]  B. Gold,et al.  Colorimetric microwell plate detection of the factor V Leiden mutation. , 2000, Clinical chemistry.

[5]  L. Kluijtmans,et al.  Accurate and rapid "multiplex heteroduplexing" method for genotyping key enzymes involved in folate/homocysteine metabolism. , 2000, Clinical chemistry.

[6]  R. Schwaab,et al.  Allelic Discrimination of Factor V Leiden Using a 5’ Nuclease Assay , 1999, Thrombosis and Haemostasis.

[7]  A. Morley,et al.  Rapid detection of the factor V Leiden (1691 G > A) and haemochromatosis (845 G > A) mutation by fluorescence resonance energy transfer (FRET) and real time PCR. , 1999, Journal of clinical pathology.

[8]  D Ryan,et al.  Non-PCR-dependent detection of the factor V Leiden mutation from genomic DNA using a homogeneous invader microtiter plate assay. , 1999, Molecular diagnosis : a journal devoted to the understanding of human disease through the clinical application of molecular biology.

[9]  I. Mcdowell,et al.  Genotyping method for methylenetetrahydrofolate reductase (C677T thermolabile variant) using heteroduplex technology. , 1998, Clinical chemistry.

[10]  T. Walsh,et al.  PCR bias toward the wild-type k-ras and p53 sequences: implications for PCR detection of mutations and cancer diagnosis. , 1998, BioTechniques.

[11]  P. Collins,et al.  Factor V Leiden (G1691A), the Prothrombin 3’-Untranslated Region Variant (G20210A) and Thermolabile Methylenetetrahydrofolate Reductase (C677T): A Single Genetic Test Genotypes all Three Loci – Determination of Frequencies in the S. Wales Population of the UK , 1998, Thrombosis and Haemostasis.

[12]  P. Ridker,et al.  Ethnic distribution of factor V Leiden in 4047 men and women. Implications for venous thromboembolism screening. , 1997, JAMA.

[13]  H. Liebman,et al.  Evaluation of a tissue factor dependent factor V assay to detect factor V Leiden: demonstration of high sensitivity and specificity for a generally applicable assay for activated protein C resistance , 1996, British journal of haematology.

[14]  L. Ballering,et al.  Chemiluminescent Detection of Factor V Leiden in a Routine Laboratory , 1996, Annals of clinical biochemistry.

[15]  N. Kirschbaum,et al.  The Polymerase Chain Reaction with Sequence Specific Primers for the Detection of the Factor V Mutation Associated with Activated Protein C Resistance , 1995, Thrombosis and Haemostasis.

[16]  P. Ridker,et al.  Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men. , 1995, The New England journal of medicine.

[17]  P. Reitsma,et al.  High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance) , 1995, Blood.

[18]  Pieter H. Reitsma,et al.  Mutation in blood coagulation factor V associated with resistance to activated protein C , 1994, Nature.

[19]  J. Bidwell,et al.  Genetic Diagnosis of Factor V Leiden Using Heteroduplex Technology , 1997, Thrombosis and Haemostasis.